The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib trial of vactosertib in combination with pomalidomide in relapsed multiple myeloma: A corticosteroid-free approach by targeting TGF-β signaling pathway.
 
Ehsan Malek
Consulting or Advisory Role - Sanofi; Takeda
Speakers' Bureau - Amgen; Janssen; Sanofi; Takeda
Research Funding - Cumberland Pharmaceuticals; MedPacto
Travel, Accommodations, Expenses - Amgen; Janssen; Takeda
 
Sunjin Hwang
Employment - medpacto
Leadership - medpacto
Stock and Other Ownership Interests - MedPacto
 
Paolo Fabrizio Caimi
Consulting or Advisory Role - ADC Therapeutics; Amgen; Bayer; Epizyme; Kite, a Gilead company; Verastem
Speakers' Bureau - Celgene
Patents, Royalties, Other Intellectual Property - XaTEC patent holder (I)
 
Leland L. Metheny
Consulting or Advisory Role - Pharmacosmos
Speakers' Bureau - Incyte; Takeda
Research Funding - Pfizer (Inst)
 
Benjamin Kent Tomlinson
No Relationships to Disclose
 
Brenda W. Cooper
No Relationships to Disclose
 
Kirsten M. Boughan
No Relationships to Disclose
 
Folashade Otegbeye
No Relationships to Disclose
 
Molly Gallogly
No Relationships to Disclose
 
James Joseph Driscoll
No Relationships to Disclose
 
Marcos J.G. De Lima
Consulting or Advisory Role - Celgene; Incyte; Pfizer; Pharmacyclics
Research Funding - Celgene; Pfizer